U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec 550.100 Apple Butter - Adulteration with Mold; Rodent Filth, Insect
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec 550.100 Apple Butter - Adulteration with Mold; Rodent Filth, Insect November 2005

Final
Issued by:
Guidance Issuing Office
Center for Food Safety and Applied Nutrition
Office of Regulatory Affairs

REGULATORY ACTION GUIDANCE:

The following represents the criteria for direct reference seizure *requests to the Office of Human and Animal Food Operations (OHAFO) in consultation with the Office of Enforcement and Import Operations (OEIO) and CFSAN, and for direct citation by the appropriate Field Office within the Human and Animal Food Program*:

A minimum of six subsamples is required for examination.

1. Mold: The apple butter has an average mold count of 12% or more;

or

2. Rodent Filth: The apple butter contains an average of 4 or more rodent hairs per 100 grams;

or

3. Insects: The apple butter contains an average of 5 or more whole or equivalent insects (not counting mites, aphids, thrips or scale insects) per 100 grams.

REMARKS:

Seizures of canned apple butter must be discussed with the U.S. Department of Agriculture. *E-mail* or FAX the following information to CFSAN/Office of *Compliance*/Division of Enforcement (HFS-605) and await reply before proceeding:

Sample Number
Date of Shipment
Article Involved
Dealer
Amount of Lot
Shipper
Codes
Analytical Conclusions

SPECIMEN CHARGE:

Article adulterated when introduced into and while in interstate commerce, within the meaning of 21 U.S.C. 342(a)(3), in that it consists wholly or in part of a filthy substance by reason of presence therein of insects and rodent hairs; and of a decomposed substance by reason of presence therein of decomposed apple butter.

*Material between asterisks is new or revised*
Issued: 10/1/80 Revised: 3/95, 5/2005 Updated: 11/29/05


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

 
Back to Top